Biostar Pharmaceuticals, Inc.
SEC CIK 1418133 · BSPM · last insider filing 2018-02-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Chen Melissa Fan | Director | filed 2018 - 2018 |
| Shang Zhongyang | Director | filed 2013 - 2013 |
| Wang Ronghua | Director · Chairman, CEO | filed 2011 - 2011 |
| Liu Qinghua | Director | filed 2011 - 2011 |
| Wu Haipeng | Director | filed 2011 - 2011 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wang Zhenghong | Chief Operating Officer | filed 2013 - 2013 |
| Pan Zibing | Chief Financial Officer | filed 2011 - 2012 |
| Zhang Amei | Chief Operating Officer | filed 2011 - 2011 |
| Chen Deyin | Chief Financial Officer | filed 2010 - 2010 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.